Reaffirming our values: the Journal of the National Cancer Institute's commitment to excellence and society.
Reaffirming our values: the Journal of the National Cancer Institute's commitment to excellence and society.
复制标题
重申我们的价值观：《国家癌症研究所杂志》对卓越和社会的承诺。
DOI：
10.1093/jnci/djad220
复制
发表时间：
2024
期刊：
影响因子：
--
通讯作者：
Eduardo L Franco
中科院分区：
文献类型：
--
作者：
Eduardo L Franco
该研究所以其首字母缩写JNCI广为人知，以其对卓越的承诺而闻名。按照每一个衡量标准和声誉标准，这本医学杂志都是肿瘤学和癌症研究领域竞争激烈的学术出版领域的领先者之一。JNCI为医药和公共卫生带来的科学知识是其品牌认知度的核心。当然，外部影响指标不断吸引着我们的内容，但回过头来看，正是对科学质量、伦理原则和学术知识的关注，集中体现了与JNCI不可磨灭的无形价值。我们的读者意识到，学术出版的世界正在迅速变化。开放获取模式正逐渐成为规则，而不是例外。对出版商来说，推出强调科学的合理性而不是新颖性和感知到的影响的巨型期刊在经济上是成功的。这导致一些不良行为者利用作者付费开放获取模式带来的机会。同行评议和印前存档的替代模式已经在行业中流行起来，并受到作者的好评。此外，高端医学期刊的出版商越来越多地利用自己的品牌认知度推出后代专业期刊，吸引希望与母期刊名称相关的作者投稿。其中很多都是肿瘤学或癌症医学的标题。在价值观、原则和出版模式处于如此不断变化的状态下，JNCI如何保持甚至提高它的声誉？我们的编辑愿景不是建立在当今时代的时代精神之上，而是建立在结构上永远无懈可击的支柱上，例如对我们的读者的价值、学术、科学有效性、伦理、促进终身学习环境的促进，以及对社会负责的多样性、公平和包容(DEI)议程的追求。我们通过将地理添加到性别、种族和经济手段的核心命题结构中来解释后者。其理由不仅仅是一种正义事业的同义反复声明；追求全球肿瘤学议程也是一种务实的战略，它将使我们的内容多样化，提供关于癌症控制和护理的突出证据，这可能会影响最需要它的政策。因此，我们应该承诺
Institute—known more widely by its acronym JNCI—is recognized for its commitment to excellence. By every metric and reputational criterion, this medical journal is among the leaders in the highly competitive academic publishing space for oncology and cancer research. The scientific knowledge that JNCI brings to medicine and public health is central to its brand recognition. Surely, external metrics of impact keep attracting content to us, but, in retrospect, it is the attention to the quality of science, ethical principles, and scholarship that epitomize the intangible values indelibly associated with JNCI. Our readers are aware that the world of academic publishing is changing rapidly. The open access model is gradually becoming the rule rather than the exception. Launching mega-journals that emphasize the soundness of science over novelty and perceived impact has been economically successful for publishers. This has led some bad actors to take advantage of the opportunity brought by the author-pays open access model. Alternative models of peer review and preprint archiving have become popular in the industry and well received by authors. In addition, publishers of premium medical journals are increasingly leveraging their brand recognition to launch offspring specialty journals that attract submissions from authors expecting to be associated with the name of the parent journal. Many of these are oncology or cancer medicine titles.How can JNCI maintain its reputation and even enhance it at a time when values, principles, and publishing models are in such a state of flux? Our editorial vision is anchored not on the zeitgeist of the present era but on pillars that will always be structurally unassailable, such as value to our readers, scholarship, scientific validity, ethics, promotion of a life-long learning environment, and the pursuit of a socially responsible agenda of diversity, equity, and inclusion (DEI). We interpret the latter by adding geography to the core DEI constructs of gender, race, and economic means. The rationale is more than a tautological statement of being a just cause; pursuing a global oncology agenda is also a pragmatic strategy, which will diversify our content with prominent evidence on cancer control and care that is likely to influence policy where it is most needed. We should thus commit
DOI：
10.1016/s1470-2045(17)30698-8
发表时间：
2017-11
期刊：
The Lancet. Oncology
影响因子：
--
作者：
Jaffee EM;Dang CV;Agus DB;Alexander BM;Anderson KC;Ashworth A;Barker AD;Bastani R;Bhatia S;Bluestone JA;Brawley O;Butte AJ;Coit DG;Davidson NE;Davis M;DePinho RA;Diasio RB;Draetta G;Frazier AL;Futreal A;Gambhir SS;Ganz PA;Garraway L;Gerson S;Gupta S;Heath J;Hoffman RI;Hudis C;Hughes-Halbert C;Ibrahim R;Jadvar H;Kavanagh B;Kittles R;Le QT;Lippman SM;Mankoff D;Mardis ER;Mayer DK;McMasters K;Meropol NJ;Mitchell B;Naredi P;Ornish D;Pawlik TM;Peppercorn J;Pomper MG;Raghavan D;Ritchie C;Schwarz SW;Sullivan R;Wahl R;Wolchok JD;Wong SL;Yung A
通讯作者：
Yung A